Clinical Trial Update: Ibrutinib, Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a combination of ibrutinib, idarubicin, and cytarabine in adults with relapsed or refractory acute myeloid leukemia; the study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Ibrutinib (ibrutinib)
• Idarubicin (idarubicin)

Snippet

Sponsor: Steven E. Coutre | Conditions: Recurrent Adult Acute Myeloid Leukemia | Phase 1 | Status: TERMINATED